IMWG consensus on maintenance therapy in multiple myeloma
Identifieur interne : 005B74 ( Main/Exploration ); précédent : 005B73; suivant : 005B75IMWG consensus on maintenance therapy in multiple myeloma
Auteurs : Heinz Ludwig [Autriche] ; Brian G. M. Durie [États-Unis] ; Philip Mccarthy [États-Unis] ; Antonio Palumbo [Italie] ; Jesus San Miguel [Espagne] ; Bart Barlogie [États-Unis] ; Gareth Morgan [Royaume-Uni] ; Pieter Sonneveld [Pays-Bas] ; Andrew Spencer [Australie] ; Kenneth C. Andersen [États-Unis] ; Thierry Facon [France] ; Keith A. Stewart [États-Unis] ; Hermann Einsele [Allemagne] ; Maria-Victoria Mateos [Espagne] ; Pierre Wijermans [Pays-Bas] ; Anders Waage [Norvège] ; Meral Beksac [Turquie] ; Paul G. Richardson [États-Unis] ; Cyrille Hulin [France] ; Ruben Niesvizky [États-Unis] ; Henk Lokhorst [Pays-Bas] ; Ola Landgren [États-Unis] ; P. Leif Bergsagel [États-Unis] ; Robert Orlowski [États-Unis] ; Axel Hinke [Allemagne] ; Michele Cavo [Italie] ; Michel Attal [France]Source :
- Blood [ 0006-4971 ] ; 2012.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Maintaining results of successful induction therapy is an important goal in multiple myeloma. Here, members of the International Myeloma Working Group review the relevant data. Thalidomide maintenance therapy after autologous stem cell transplantation improved the quality of response and increased progression-free survival (PFS) significantly in all 6 studies and overall survival (OS) in 3 of them. In elderly patients, 2 trials showed a significant prolongation of PFS, but no improvement in OS. A meta-analysis revealed a significant risk reduction for PFS/eventfree survival and death. The role of thalidomide maintenance after melphalan, prednisone, and thalidomide is not well established. Two trials with lenalidomide maintenance treatment after autologous stem cell transplantation and one study after conventional melphalan, prednisone, and lenalidomide induction therapy showed a significant risk reduction for PFS and an increase in OS in one of the transplant trials. Maintenance therapy with single-agent bortezomib or in combination with thalidomide or prednisone has been studied. One trial revealed a significantly increased OS with a bortezomib-based induction and bortezomib maintenance therapy compared with conventional induction and thalidomide maintenance treatment. Maintenance treatment can be associated with significant side effects, and none of the drugs evaluated is approved for maintenance therapy. Treatment decisions for individual patients must balance potential benefits and risks carefully, as a widely agreed-on standard is not established.
Url:
Affiliations:
- Allemagne, Australie, Autriche, Espagne, France, Italie, Norvège, Pays-Bas, Royaume-Uni, Turquie, États-Unis
- Angleterre, Bavière, District de Basse-Franconie, Grand Est, Grand Londres, Hauts-de-France, Hollande-Méridionale, Lorraine (région), Midi-Pyrénées, Nord-Pas-de-Calais, Occitanie (région administrative), Piémont, Trøndelag, Utrecht (province), Vienne (Autriche)
- Lille, Londres, Nancy, Rotterdam, Toulouse, Trondheim, Turin, Utrecht, Vienne (Autriche), Wurtzbourg
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001456
- to stream PascalFrancis, to step Curation: 004A56
- to stream PascalFrancis, to step Checkpoint: 001040
- to stream Main, to step Merge: 005E75
- to stream Pmc, to step Corpus: 002E73
- to stream Pmc, to step Curation: 002D22
- to stream Pmc, to step Checkpoint: 001F03
- to stream Ncbi, to step Merge: 000C95
- to stream Ncbi, to step Curation: 000C95
- to stream Ncbi, to step Checkpoint: 000C95
- to stream Main, to step Merge: 005587
- to stream Main, to step Curation: 005B74
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">IMWG consensus on maintenance therapy in multiple myeloma</title>
<author><name sortKey="Ludwig, Heinz" sort="Ludwig, Heinz" uniqKey="Ludwig H" first="Heinz" last="Ludwig">Heinz Ludwig</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Medicine I, Center for Oncology and Hematology, Wilhelminenspital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Durie, Brian G M" sort="Durie, Brian G M" uniqKey="Durie B" first="Brian G. M." last="Durie">Brian G. M. Durie</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Southwest Oncology Group, International Myeloma Foundation and Cedars Sinai Comprehensive Cancer Center</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Los Angeles, CA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mccarthy, Philip" sort="Mccarthy, Philip" uniqKey="Mccarthy P" first="Philip" last="Mccarthy">Philip Mccarthy</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Roswell Park Cancer Institute</s1>
<s2>Buffalo, NY</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Roswell Park Cancer Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palumbo, Antonio" sort="Palumbo, Antonio" uniqKey="Palumbo A" first="Antonio" last="Palumbo">Antonio Palumbo</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliera Universitaria S. Giovanni Battista</s1>
<s2>Torino</s2>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Miguel, Jesus San" sort="Miguel, Jesus San" uniqKey="Miguel J" first="Jesus San" last="Miguel">Jesus San Miguel</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>University Hospital of Salamanca</s1>
<s2>Salamanca</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>University Hospital of Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barlogie, Bart" sort="Barlogie, Bart" uniqKey="Barlogie B" first="Bart" last="Barlogie">Bart Barlogie</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, AR</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Little Rock, AR</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morgan, Gareth" sort="Morgan, Gareth" uniqKey="Morgan G" first="Gareth" last="Morgan">Gareth Morgan</name>
<affiliation wicri:level="3"><inist:fA14 i1="07"><s1>Haemato-Oncology Unit, Royal Marsden Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sonneveld, Pieter" sort="Sonneveld, Pieter" uniqKey="Sonneveld P" first="Pieter" last="Sonneveld">Pieter Sonneveld</name>
<affiliation wicri:level="3"><inist:fA14 i1="08"><s1>Department of Hematology, Erasmus MC</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Clinical Haematology/Bone Marrow Transplant Department, Alfred Hospital</s1>
<s2>Melbourne, Victoria</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Andersen, Kenneth C" sort="Andersen, Kenneth C" uniqKey="Andersen K" first="Kenneth C." last="Andersen">Kenneth C. Andersen</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Dana-Farber Cancer Institute, Medical Oncology</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Boston, MA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Facon, Thierry" sort="Facon, Thierry" uniqKey="Facon T" first="Thierry" last="Facon">Thierry Facon</name>
<affiliation wicri:level="3"><inist:fA14 i1="11"><s1>Department of Hematology, Hospital Claude Huriez</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stewart, Keith A" sort="Stewart, Keith A" uniqKey="Stewart K" first="Keith A." last="Stewart">Keith A. Stewart</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Division of Hematology-Oncology, Mayo Clinic</s1>
<s2>Scottsdale, AZ</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Scottsdale, AZ</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Einsele, Hermann" sort="Einsele, Hermann" uniqKey="Einsele H" first="Hermann" last="Einsele">Hermann Einsele</name>
<affiliation wicri:level="3"><inist:fA14 i1="13"><s1>Department of Internal Medicine II, University Hospital</s1>
<s2>Würzburg</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Basse-Franconie</region>
<settlement type="city">Wurtzbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mateos, Maria Victoria" sort="Mateos, Maria Victoria" uniqKey="Mateos M" first="Maria-Victoria" last="Mateos">Maria-Victoria Mateos</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>University Hospital of Salamanca</s1>
<s2>Salamanca</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>University Hospital of Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wijermans, Pierre" sort="Wijermans, Pierre" uniqKey="Wijermans P" first="Pierre" last="Wijermans">Pierre Wijermans</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Haga Hospital</s1>
<s2>The Hague</s2>
<s3>NLD</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<wicri:noRegion>Haga Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Waage, Anders" sort="Waage, Anders" uniqKey="Waage A" first="Anders" last="Waage">Anders Waage</name>
<affiliation wicri:level="3"><inist:fA14 i1="15"><s1>Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology</s1>
<s2>Trondheim</s2>
<s3>NOR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Norvège</country>
<placeName><settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beksac, Meral" sort="Beksac, Meral" uniqKey="Beksac M" first="Meral" last="Beksac">Meral Beksac</name>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Department of Microbiology and Clinical Microbiology, Ankara University School of Medicine, Ibn-i Sina Hospital</s1>
<s2>Ankara</s2>
<s3>TUR</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>Turquie</country>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Richardson, Paul G" sort="Richardson, Paul G" uniqKey="Richardson P" first="Paul G." last="Richardson">Paul G. Richardson</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Dana-Farber Cancer Institute, Medical Oncology</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Boston, MA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hulin, Cyrille" sort="Hulin, Cyrille" uniqKey="Hulin C" first="Cyrille" last="Hulin">Cyrille Hulin</name>
<affiliation wicri:level="3"><inist:fA14 i1="17"><s1>Hematology Department, University Hospital</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Grand Est</region>
<region type="old region">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Niesvizky, Ruben" sort="Niesvizky, Ruben" uniqKey="Niesvizky R" first="Ruben" last="Niesvizky">Ruben Niesvizky</name>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Weill Cornell Medical College</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Weill Cornell Medical College</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lokhorst, Henk" sort="Lokhorst, Henk" uniqKey="Lokhorst H" first="Henk" last="Lokhorst">Henk Lokhorst</name>
<affiliation wicri:level="3"><inist:fA14 i1="19"><s1>University Medical Center</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Landgren, Ola" sort="Landgren, Ola" uniqKey="Landgren O" first="Ola" last="Landgren">Ola Landgren</name>
<affiliation wicri:level="1"><inist:fA14 i1="20"><s1>Metabolism Branch, National Cancer Institute, National Institutes of Health</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bergsagel, P Leif" sort="Bergsagel, P Leif" uniqKey="Bergsagel P" first="P. Leif" last="Bergsagel">P. Leif Bergsagel</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Division of Hematology-Oncology, Mayo Clinic</s1>
<s2>Scottsdale, AZ</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Scottsdale, AZ</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Orlowski, Robert" sort="Orlowski, Robert" uniqKey="Orlowski R" first="Robert" last="Orlowski">Robert Orlowski</name>
<affiliation wicri:level="1"><inist:fA14 i1="21"><s1>Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center</s1>
<s2>Houston, TX</s2>
<s3>USA</s3>
<sZ>24 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Houston, TX</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hinke, Axel" sort="Hinke, Axel" uniqKey="Hinke A" first="Axel" last="Hinke">Axel Hinke</name>
<affiliation wicri:level="1"><inist:fA14 i1="22"><s1>WISP Research Institute</s1>
<s2>Langenfeld</s2>
<s3>DEU</s3>
<sZ>25 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Langenfeld</wicri:noRegion>
<wicri:noRegion>WISP Research Institute</wicri:noRegion>
<wicri:noRegion>WISP Research Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cavo, Michele" sort="Cavo, Michele" uniqKey="Cavo M" first="Michele" last="Cavo">Michele Cavo</name>
<affiliation wicri:level="1"><inist:fA14 i1="23"><s1>Seragnoli Institute of Haematology, Bologna School of Medicine, S. Orsola's University Hospital</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>26 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Bologna</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Attal, Michel" sort="Attal, Michel" uniqKey="Attal M" first="Michel" last="Attal">Michel Attal</name>
<affiliation wicri:level="3"><inist:fA14 i1="24"><s1>Service d'Hématologie. Hospital Purpan</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>27 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0187416</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0187416 INIST</idno>
<idno type="RBID">Pascal:12-0187416</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001456</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004A56</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001040</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001040</idno>
<idno type="wicri:doubleKey">0006-4971:2012:Ludwig H:imwg:consensus:on</idno>
<idno type="wicri:Area/Main/Merge">005E75</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321864</idno>
<idno type="RBID">PMC:3321864</idno>
<idno type="wicri:Area/Pmc/Corpus">002E73</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002E73</idno>
<idno type="wicri:Area/Pmc/Curation">002D22</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002D22</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001F03</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001F03</idno>
<idno type="wicri:Area/Ncbi/Merge">000C95</idno>
<idno type="wicri:Area/Ncbi/Curation">000C95</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C95</idno>
<idno type="wicri:doubleKey">0006-4971:2012:Ludwig H:imwg:consensus:on</idno>
<idno type="wicri:Area/Main/Merge">005587</idno>
<idno type="wicri:Area/Main/Curation">005B74</idno>
<idno type="wicri:Area/Main/Exploration">005B74</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">IMWG consensus on maintenance therapy in multiple myeloma</title>
<author><name sortKey="Ludwig, Heinz" sort="Ludwig, Heinz" uniqKey="Ludwig H" first="Heinz" last="Ludwig">Heinz Ludwig</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Medicine I, Center for Oncology and Hematology, Wilhelminenspital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Durie, Brian G M" sort="Durie, Brian G M" uniqKey="Durie B" first="Brian G. M." last="Durie">Brian G. M. Durie</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Southwest Oncology Group, International Myeloma Foundation and Cedars Sinai Comprehensive Cancer Center</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Los Angeles, CA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mccarthy, Philip" sort="Mccarthy, Philip" uniqKey="Mccarthy P" first="Philip" last="Mccarthy">Philip Mccarthy</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Roswell Park Cancer Institute</s1>
<s2>Buffalo, NY</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Roswell Park Cancer Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palumbo, Antonio" sort="Palumbo, Antonio" uniqKey="Palumbo A" first="Antonio" last="Palumbo">Antonio Palumbo</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliera Universitaria S. Giovanni Battista</s1>
<s2>Torino</s2>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Miguel, Jesus San" sort="Miguel, Jesus San" uniqKey="Miguel J" first="Jesus San" last="Miguel">Jesus San Miguel</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>University Hospital of Salamanca</s1>
<s2>Salamanca</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>University Hospital of Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barlogie, Bart" sort="Barlogie, Bart" uniqKey="Barlogie B" first="Bart" last="Barlogie">Bart Barlogie</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences</s1>
<s2>Little Rock, AR</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Little Rock, AR</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morgan, Gareth" sort="Morgan, Gareth" uniqKey="Morgan G" first="Gareth" last="Morgan">Gareth Morgan</name>
<affiliation wicri:level="3"><inist:fA14 i1="07"><s1>Haemato-Oncology Unit, Royal Marsden Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sonneveld, Pieter" sort="Sonneveld, Pieter" uniqKey="Sonneveld P" first="Pieter" last="Sonneveld">Pieter Sonneveld</name>
<affiliation wicri:level="3"><inist:fA14 i1="08"><s1>Department of Hematology, Erasmus MC</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Clinical Haematology/Bone Marrow Transplant Department, Alfred Hospital</s1>
<s2>Melbourne, Victoria</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Andersen, Kenneth C" sort="Andersen, Kenneth C" uniqKey="Andersen K" first="Kenneth C." last="Andersen">Kenneth C. Andersen</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Dana-Farber Cancer Institute, Medical Oncology</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Boston, MA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Facon, Thierry" sort="Facon, Thierry" uniqKey="Facon T" first="Thierry" last="Facon">Thierry Facon</name>
<affiliation wicri:level="3"><inist:fA14 i1="11"><s1>Department of Hematology, Hospital Claude Huriez</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stewart, Keith A" sort="Stewart, Keith A" uniqKey="Stewart K" first="Keith A." last="Stewart">Keith A. Stewart</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Division of Hematology-Oncology, Mayo Clinic</s1>
<s2>Scottsdale, AZ</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Scottsdale, AZ</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Einsele, Hermann" sort="Einsele, Hermann" uniqKey="Einsele H" first="Hermann" last="Einsele">Hermann Einsele</name>
<affiliation wicri:level="3"><inist:fA14 i1="13"><s1>Department of Internal Medicine II, University Hospital</s1>
<s2>Würzburg</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Basse-Franconie</region>
<settlement type="city">Wurtzbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mateos, Maria Victoria" sort="Mateos, Maria Victoria" uniqKey="Mateos M" first="Maria-Victoria" last="Mateos">Maria-Victoria Mateos</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>University Hospital of Salamanca</s1>
<s2>Salamanca</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>University Hospital of Salamanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wijermans, Pierre" sort="Wijermans, Pierre" uniqKey="Wijermans P" first="Pierre" last="Wijermans">Pierre Wijermans</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Haga Hospital</s1>
<s2>The Hague</s2>
<s3>NLD</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<wicri:noRegion>Haga Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Waage, Anders" sort="Waage, Anders" uniqKey="Waage A" first="Anders" last="Waage">Anders Waage</name>
<affiliation wicri:level="3"><inist:fA14 i1="15"><s1>Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology</s1>
<s2>Trondheim</s2>
<s3>NOR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Norvège</country>
<placeName><settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beksac, Meral" sort="Beksac, Meral" uniqKey="Beksac M" first="Meral" last="Beksac">Meral Beksac</name>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Department of Microbiology and Clinical Microbiology, Ankara University School of Medicine, Ibn-i Sina Hospital</s1>
<s2>Ankara</s2>
<s3>TUR</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>Turquie</country>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Richardson, Paul G" sort="Richardson, Paul G" uniqKey="Richardson P" first="Paul G." last="Richardson">Paul G. Richardson</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Dana-Farber Cancer Institute, Medical Oncology</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Boston, MA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hulin, Cyrille" sort="Hulin, Cyrille" uniqKey="Hulin C" first="Cyrille" last="Hulin">Cyrille Hulin</name>
<affiliation wicri:level="3"><inist:fA14 i1="17"><s1>Hematology Department, University Hospital</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Grand Est</region>
<region type="old region">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Niesvizky, Ruben" sort="Niesvizky, Ruben" uniqKey="Niesvizky R" first="Ruben" last="Niesvizky">Ruben Niesvizky</name>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Weill Cornell Medical College</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Weill Cornell Medical College</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lokhorst, Henk" sort="Lokhorst, Henk" uniqKey="Lokhorst H" first="Henk" last="Lokhorst">Henk Lokhorst</name>
<affiliation wicri:level="3"><inist:fA14 i1="19"><s1>University Medical Center</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Landgren, Ola" sort="Landgren, Ola" uniqKey="Landgren O" first="Ola" last="Landgren">Ola Landgren</name>
<affiliation wicri:level="1"><inist:fA14 i1="20"><s1>Metabolism Branch, National Cancer Institute, National Institutes of Health</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bergsagel, P Leif" sort="Bergsagel, P Leif" uniqKey="Bergsagel P" first="P. Leif" last="Bergsagel">P. Leif Bergsagel</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Division of Hematology-Oncology, Mayo Clinic</s1>
<s2>Scottsdale, AZ</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Scottsdale, AZ</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Orlowski, Robert" sort="Orlowski, Robert" uniqKey="Orlowski R" first="Robert" last="Orlowski">Robert Orlowski</name>
<affiliation wicri:level="1"><inist:fA14 i1="21"><s1>Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center</s1>
<s2>Houston, TX</s2>
<s3>USA</s3>
<sZ>24 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Houston, TX</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hinke, Axel" sort="Hinke, Axel" uniqKey="Hinke A" first="Axel" last="Hinke">Axel Hinke</name>
<affiliation wicri:level="1"><inist:fA14 i1="22"><s1>WISP Research Institute</s1>
<s2>Langenfeld</s2>
<s3>DEU</s3>
<sZ>25 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Langenfeld</wicri:noRegion>
<wicri:noRegion>WISP Research Institute</wicri:noRegion>
<wicri:noRegion>WISP Research Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cavo, Michele" sort="Cavo, Michele" uniqKey="Cavo M" first="Michele" last="Cavo">Michele Cavo</name>
<affiliation wicri:level="1"><inist:fA14 i1="23"><s1>Seragnoli Institute of Haematology, Bologna School of Medicine, S. Orsola's University Hospital</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>26 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Bologna</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Attal, Michel" sort="Attal, Michel" uniqKey="Attal M" first="Michel" last="Attal">Michel Attal</name>
<affiliation wicri:level="3"><inist:fA14 i1="24"><s1>Service d'Hématologie. Hospital Purpan</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>27 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Blood</title>
<title level="j" type="abbreviated">Blood</title>
<idno type="ISSN">0006-4971</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Blood</title>
<title level="j" type="abbreviated">Blood</title>
<idno type="ISSN">0006-4971</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Consensus</term>
<term>Hematology</term>
<term>Maintenance treatment</term>
<term>Myeloma</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Myélome</term>
<term>Consensus</term>
<term>Traitement entretien</term>
<term>Hématologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Maintaining results of successful induction therapy is an important goal in multiple myeloma. Here, members of the International Myeloma Working Group review the relevant data. Thalidomide maintenance therapy after autologous stem cell transplantation improved the quality of response and increased progression-free survival (PFS) significantly in all 6 studies and overall survival (OS) in 3 of them. In elderly patients, 2 trials showed a significant prolongation of PFS, but no improvement in OS. A meta-analysis revealed a significant risk reduction for PFS/eventfree survival and death. The role of thalidomide maintenance after melphalan, prednisone, and thalidomide is not well established. Two trials with lenalidomide maintenance treatment after autologous stem cell transplantation and one study after conventional melphalan, prednisone, and lenalidomide induction therapy showed a significant risk reduction for PFS and an increase in OS in one of the transplant trials. Maintenance therapy with single-agent bortezomib or in combination with thalidomide or prednisone has been studied. One trial revealed a significantly increased OS with a bortezomib-based induction and bortezomib maintenance therapy compared with conventional induction and thalidomide maintenance treatment. Maintenance treatment can be associated with significant side effects, and none of the drugs evaluated is approved for maintenance therapy. Treatment decisions for individual patients must balance potential benefits and risks carefully, as a widely agreed-on standard is not established.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Autriche</li>
<li>Espagne</li>
<li>France</li>
<li>Italie</li>
<li>Norvège</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
<li>Turquie</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Bavière</li>
<li>District de Basse-Franconie</li>
<li>Grand Est</li>
<li>Grand Londres</li>
<li>Hauts-de-France</li>
<li>Hollande-Méridionale</li>
<li>Lorraine (région)</li>
<li>Midi-Pyrénées</li>
<li>Nord-Pas-de-Calais</li>
<li>Occitanie (région administrative)</li>
<li>Piémont</li>
<li>Trøndelag</li>
<li>Utrecht (province)</li>
<li>Vienne (Autriche)</li>
</region>
<settlement><li>Lille</li>
<li>Londres</li>
<li>Nancy</li>
<li>Rotterdam</li>
<li>Toulouse</li>
<li>Trondheim</li>
<li>Turin</li>
<li>Utrecht</li>
<li>Vienne (Autriche)</li>
<li>Wurtzbourg</li>
</settlement>
</list>
<tree><country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Ludwig, Heinz" sort="Ludwig, Heinz" uniqKey="Ludwig H" first="Heinz" last="Ludwig">Heinz Ludwig</name>
</region>
</country>
<country name="États-Unis"><noRegion><name sortKey="Durie, Brian G M" sort="Durie, Brian G M" uniqKey="Durie B" first="Brian G. M." last="Durie">Brian G. M. Durie</name>
</noRegion>
<name sortKey="Andersen, Kenneth C" sort="Andersen, Kenneth C" uniqKey="Andersen K" first="Kenneth C." last="Andersen">Kenneth C. Andersen</name>
<name sortKey="Barlogie, Bart" sort="Barlogie, Bart" uniqKey="Barlogie B" first="Bart" last="Barlogie">Bart Barlogie</name>
<name sortKey="Bergsagel, P Leif" sort="Bergsagel, P Leif" uniqKey="Bergsagel P" first="P. Leif" last="Bergsagel">P. Leif Bergsagel</name>
<name sortKey="Landgren, Ola" sort="Landgren, Ola" uniqKey="Landgren O" first="Ola" last="Landgren">Ola Landgren</name>
<name sortKey="Mccarthy, Philip" sort="Mccarthy, Philip" uniqKey="Mccarthy P" first="Philip" last="Mccarthy">Philip Mccarthy</name>
<name sortKey="Niesvizky, Ruben" sort="Niesvizky, Ruben" uniqKey="Niesvizky R" first="Ruben" last="Niesvizky">Ruben Niesvizky</name>
<name sortKey="Orlowski, Robert" sort="Orlowski, Robert" uniqKey="Orlowski R" first="Robert" last="Orlowski">Robert Orlowski</name>
<name sortKey="Richardson, Paul G" sort="Richardson, Paul G" uniqKey="Richardson P" first="Paul G." last="Richardson">Paul G. Richardson</name>
<name sortKey="Stewart, Keith A" sort="Stewart, Keith A" uniqKey="Stewart K" first="Keith A." last="Stewart">Keith A. Stewart</name>
</country>
<country name="Italie"><region name="Piémont"><name sortKey="Palumbo, Antonio" sort="Palumbo, Antonio" uniqKey="Palumbo A" first="Antonio" last="Palumbo">Antonio Palumbo</name>
</region>
<name sortKey="Cavo, Michele" sort="Cavo, Michele" uniqKey="Cavo M" first="Michele" last="Cavo">Michele Cavo</name>
</country>
<country name="Espagne"><noRegion><name sortKey="Miguel, Jesus San" sort="Miguel, Jesus San" uniqKey="Miguel J" first="Jesus San" last="Miguel">Jesus San Miguel</name>
</noRegion>
<name sortKey="Mateos, Maria Victoria" sort="Mateos, Maria Victoria" uniqKey="Mateos M" first="Maria-Victoria" last="Mateos">Maria-Victoria Mateos</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Morgan, Gareth" sort="Morgan, Gareth" uniqKey="Morgan G" first="Gareth" last="Morgan">Gareth Morgan</name>
</region>
</country>
<country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Sonneveld, Pieter" sort="Sonneveld, Pieter" uniqKey="Sonneveld P" first="Pieter" last="Sonneveld">Pieter Sonneveld</name>
</region>
<name sortKey="Lokhorst, Henk" sort="Lokhorst, Henk" uniqKey="Lokhorst H" first="Henk" last="Lokhorst">Henk Lokhorst</name>
<name sortKey="Wijermans, Pierre" sort="Wijermans, Pierre" uniqKey="Wijermans P" first="Pierre" last="Wijermans">Pierre Wijermans</name>
</country>
<country name="Australie"><noRegion><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
</noRegion>
</country>
<country name="France"><region name="Hauts-de-France"><name sortKey="Facon, Thierry" sort="Facon, Thierry" uniqKey="Facon T" first="Thierry" last="Facon">Thierry Facon</name>
</region>
<name sortKey="Attal, Michel" sort="Attal, Michel" uniqKey="Attal M" first="Michel" last="Attal">Michel Attal</name>
<name sortKey="Hulin, Cyrille" sort="Hulin, Cyrille" uniqKey="Hulin C" first="Cyrille" last="Hulin">Cyrille Hulin</name>
</country>
<country name="Allemagne"><region name="Bavière"><name sortKey="Einsele, Hermann" sort="Einsele, Hermann" uniqKey="Einsele H" first="Hermann" last="Einsele">Hermann Einsele</name>
</region>
<name sortKey="Hinke, Axel" sort="Hinke, Axel" uniqKey="Hinke A" first="Axel" last="Hinke">Axel Hinke</name>
</country>
<country name="Norvège"><region name="Trøndelag"><name sortKey="Waage, Anders" sort="Waage, Anders" uniqKey="Waage A" first="Anders" last="Waage">Anders Waage</name>
</region>
</country>
<country name="Turquie"><noRegion><name sortKey="Beksac, Meral" sort="Beksac, Meral" uniqKey="Beksac M" first="Meral" last="Beksac">Meral Beksac</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005B74 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005B74 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:12-0187416 |texte= IMWG consensus on maintenance therapy in multiple myeloma }}
This area was generated with Dilib version V0.6.33. |